Source: Virtual Congress 2020 – Antibiotic resistance: the way forward



Rating:

Share or cite this content

Citations should be made in the following way:
H. Goossens (Edegem (Antwerp), Belgium). Better diagnostics for targeted antibiotic therapy. Virtual Congress 2020 – Antibiotic resistance: the way forward

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers and rapid diagnostics in antibiotic stewardship Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections Year: 2015 Meta-analysis may not be practicable for guiding antibiotic therapy Source: Eur Respir J 2008; 31: 906-907 Year: 2008 Optimizing the target therapy development Source: ERS Research Seminar Year: 2015 Long-term antibiotic therapy Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017 The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 New methodologogic approaches to the management of antituberculous service Source: Eur Respir J 2003; 22: Suppl. 45, 381s Year: 2003 Combination therapy in the era of immunotherapy Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Paradox radiologic progression despite appropriate antituberculosis therapy Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 Antimicrobial resistance and new therapeutic options Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era Year: 2021 Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019 Rational use of tuberculosis drugs to prevent the development of drug resistance Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012